Modalis Therapeutics

4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
HolderStakeChangeFiled
Evo Fund7.61%-1.35pp2026-10-22
Life Science Innovation Management Inc.6.28%-9.02pp2025-08-12
LSIM Inc.5.02%-0.21pp2026-05-27

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 5
SBI SECURITIES Co., Ltd.3.77%2025-01-22
Osamu Nureki3.58%2024-09-25
SBI Investment Co., Ltd.0.69%2025-01-22
Haruhiko Morita0.38%2026-05-27
Evolution Capital Management LLC0.00%2026-06-19
Ownership history · 177
FiledHolderRatioChangePurpose
2024-10-08AmendedEvolution Capital Management LLC2024-10-08 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-10-08AmendedEvo Fund2024-10-08 · amended25.06%-2.17ppPure investment
2024-09-27AmendedEvolution Capital Management LLC2024-09-27 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-27AmendedEvo Fund2024-09-27 · amended27.23%-2.40ppPure investment
2024-09-26AmendedEvolution Capital Management LLC2024-09-26 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-26AmendedEvo Fund2024-09-26 · amended29.63%-5.32ppPure investment
2024-09-25AmendedEvolution Capital Management LLC2024-09-25 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-25AmendedEvo Fund2024-09-25 · amended34.95%-3.02ppPure investment
2024-09-25Osamu Nureki2024-09-253.58%-1.53ppStable shareholder
2024-09-20AmendedEvolution Capital Management LLC2024-09-20 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-20AmendedEvo Fund2024-09-20 · amended37.97%-1.02ppPure investment
2024-09-17AmendedEvolution Capital Management LLC2024-09-17 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-17AmendedEvo Fund2024-09-17 · amended38.99%-0.44ppPure investment
2024-09-12AmendedEvolution Capital Management LLC2024-09-12 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-12AmendedEvo Fund2024-09-12 · amended39.43%-1.29ppPure investment
2024-09-10AmendedEvolution Capital Management LLC2024-09-10 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-10AmendedEvo Fund2024-09-10 · amended40.72%-0.42ppPure investment
2024-09-09AmendedSBI Investment Co., Ltd.2024-09-09 · amended2.09%-0.49ppPure investment
2024-09-09AmendedSBI SECURITIES Co., Ltd.2024-09-09 · amended2.28%-0.52ppSecurities trading business
2024-09-09AmendedSBI Investment Co., Ltd.2024-09-09 · amended2.58%-0.19ppPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.